Itron (NASDAQ:ITRI) SVP John Marcolini Sells 565 Shares

Itron, Inc. (NASDAQ:ITRI) SVP John Marcolini sold 565 shares of Itron stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $70,800.15. Following the completion of the sale, the senior vice president directly owned 14,396 shares of the company’s stock, valued at approximately $1,803,962.76. This trade represents a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Itron Stock Up 0.0%

Shares of NASDAQ:ITRI traded up $0.01 during midday trading on Tuesday, hitting $124.06. 994,463 shares of the company’s stock were exchanged, compared to its average volume of 590,773. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.04 and a quick ratio of 1.75. The stock has a 50 day moving average price of $130.55 and a 200-day moving average price of $115.40. The company has a market cap of $5.67 billion, a PE ratio of 21.21, a price-to-earnings-growth ratio of 0.69 and a beta of 1.35. Itron, Inc. has a 12 month low of $90.11 and a 12 month high of $140.04.

Itron (NASDAQ:ITRI) last posted its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.33 by $0.29. The company had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. The firm’s revenue for the quarter was down .4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, sell-side analysts anticipate that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ITRI shares. TD Cowen boosted their target price on shares of Itron from $139.00 to $145.00 and gave the stock a “buy” rating in a research report on Friday, June 20th. Guggenheim reaffirmed a “buy” rating and issued a $155.00 price objective (up from $133.00) on shares of Itron in a research report on Monday, July 14th. Piper Sandler reduced their price objective on shares of Itron from $124.00 to $121.00 and set a “neutral” rating for the company in a research report on Monday, May 5th. Johnson Rice downgraded shares of Itron from a “buy” rating to an “accumulate” rating in a research report on Friday, August 1st. Finally, JPMorgan Chase & Co. raised shares of Itron from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $128.00 to $145.00 in a research report on Thursday, July 31st. Eleven research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $136.25.

Hedge Funds Weigh In On Itron

A number of institutional investors have recently made changes to their positions in the stock. State of Wyoming bought a new position in shares of Itron in the 2nd quarter worth $214,000. Castleark Management LLC boosted its position in Itron by 29.2% during the 2nd quarter. Castleark Management LLC now owns 62,330 shares of the scientific and technical instruments company’s stock valued at $8,204,000 after buying an additional 14,100 shares during the period. Public Sector Pension Investment Board boosted its position in Itron by 8.6% during the 2nd quarter. Public Sector Pension Investment Board now owns 155,372 shares of the scientific and technical instruments company’s stock valued at $20,452,000 after buying an additional 12,354 shares during the period. FORA Capital LLC purchased a new stake in Itron during the 2nd quarter valued at $665,000. Finally, Tower Research Capital LLC TRC boosted its position in Itron by 434.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,798 shares of the scientific and technical instruments company’s stock valued at $763,000 after buying an additional 4,714 shares during the period. Institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.